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Introduction {#sec1}
============

Regulated unwinding of the parental DNA duplex ensures that eukaryotic cells make a single copy of their chromosomes during each cell cycle ([@bib3], [@bib14]). The essential DNA helicase at replication forks is built from 11 proteins ([@bib34]), which are assembled during G1 phase and S phase in a stepwise fashion at origins of DNA replication ([@bib19]), in a process that cannot be repeated until after cell division. The six Mcm2-7 ATPases form the catalytic core of the helicase and are loaded as a double hexamer around origin DNA during G1 phase ([@bib11]). When cells enter S phase, the Cdc45 protein and the four-protein GINS complex are recruited to the Mcm2--7 core, leading to the formation of two replication forks per origin, each with an active CMG helicase ([@bib19], [@bib21], [@bib37]). To allow complete duplication of the genome, the CMG helicase must remain continuously associated with replication forks ([@bib23]). However, the convergence of opposing replication forks leads to termination of DNA synthesis and to disassembly of the CMG helicase in a regulated process ([@bib12], [@bib26], [@bib31]), the details of which are only beginning to emerge.

In budding yeast, the E3 ubiquitin ligase SCF^Dia2^ is required to ubiquitylate CMG at the end of chromosome replication ([@bib25], [@bib26]). Ubiquitylated CMG is normally disassembled so quickly that it is undetectable in wild-type cells, but it can be stabilized by inactivation of Cdc48 ([@bib26]), which is required to disrupt the ubiquitylated helicase into its component parts, namely Cdc45, Mcm2--7, and GINS. Work with extracts of *Xenopus laevis* eggs also demonstrated a role for p97/Cdc48 in release of ubiquitylated CMG from chromatin at the end of chromosome replication ([@bib18], [@bib31], [@bib41]), indicating that the principal features of DNA replication termination have been conserved throughout the course of eukaryotic evolution.

Cdc48 has many ubiquitin-binding partners that are thought to recruit the segregase to a wide range of different substrates ([@bib29]). Here, we describe a screen in budding yeast for partners of Cdc48 that are required for helicase disassembly at the end of DNA replication. Our data indicate that the Ufd1-Npl4 heterodimer recruits Cdc48 to ubiquitylated CMG at the end of DNA synthesis, leading to a revised model for the final stages of eukaryotic chromosome duplication.

Results {#sec2}
=======

Ufd1-Npl4 Promote Disassembly of Ubiquitylated CMG Helicase {#sec2.1}
-----------------------------------------------------------

To screen systematically for Cdc48 partners that are required for CMG disassembly in vivo, we assayed for persistence of the ubiquitylated CMG helicase in budding yeast cells lacking each factor, using high salt extracts that prevented in vitro ubiquitylation of CMG by SCF^Dia2^ ([@bib26]). Removal of the non-essential partners of Cdc48 did not lead to persistence of ubiquitylated CMG ([Figure S1](#mmc1){ref-type="supplementary-material"}A; CMG was isolated by immunoprecipitation of the Sld5 component of GINS) or to persistence of "old" CMG complexes from one cell cycle to the next ([Figure S1](#mmc1){ref-type="supplementary-material"}B). The same was true after conditional depletion of degron-tagged Shp1 ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D), which couples Cdc48 to a variety of essential processes, including mitosis ([@bib7]). In contrast, ubiquitylation of the CMG helicase on its Mcm7 subunit was detected in asynchronous cultures of cells with temperature-sensitive mutations in either component of the essential Ufd1-Npl4 heterodimer ([Figures 1](#fig1){ref-type="fig"}A and 1B). Ufd1-Npl4 were previously shown to be required for degradation of Cdc48 substrates in the endoplasmic reticulum ([@bib22]) but are also critical for extraction of ubiquitylated RNA polymerase II from chromatin in budding yeast ([@bib46]), as well as being important for the DNA damage response in both yeast and higher eukaryotes ([@bib2], [@bib4], [@bib10], [@bib27], [@bib33], [@bib35], [@bib39], [@bib45]).

Whereas CMG disassembly was partially defective when synchronized cultures of *ufd1-2* or *npl4-1* cells completed S phase at the restrictive temperature of 37°C, simultaneous inactivation of both factors in early S phase blocked the subsequent disassembly of CMG very efficiently ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B; note that *ufd1-2* cells showed a greater defect in CMG disassembly under these conditions than *npl4-1*). Correspondingly, inactivation of the Ufd1-Npl4 heterodimer led to accumulation of the CMG helicase with ubiquitylated Mcm7 subunit ([Figures 1](#fig1){ref-type="fig"}D and [S2](#mmc1){ref-type="supplementary-material"}C), as seen previously upon inactivation of Cdc48 ([@bib26]). These findings indicate that the Ufd1-Npl4 heterodimer is essential for disassembly of ubiquitylated CMG helicase at the end of chromosome replication in budding yeast. Consistent with this idea, the *npl4-1* mutation is synthetic lethal at a semi-permissive temperature with *dia2Δ* ([Figure 1](#fig1){ref-type="fig"}E), mirroring the synthetic lethality of *cdc48* alleles with *dia2* mutations ([@bib25]). Moreover, *ufd1-2* is synthetic sick at a semi-permissive temperature with *dia2Δ* ([Figure 1](#fig1){ref-type="fig"}E). In contrast, deletion of genes encoding the other Cdc48 adaptors is not lethal in combination with *dia2Δ* (M.M. and K.L., unpublished data).

Ufd1-Npl4 Are Required to Recruit Cdc48 to the CMG Helicase {#sec2.2}
-----------------------------------------------------------

To establish that the Ufd1-Npl4-Cdc48 complex plays a direct role in CMG disassembly, we examined the association of all three factors with the helicase, using an in vitro system for SCF^Dia2^-dependent ubiquitylation of CMG in yeast cell extracts ([@bib26]). Whereas Cdc48-Ufd1-Npl4 did not associate with the GINS complex in extracts of G1 phase cells that lacked CMG, all three factors co-purified with GINS from S phase cell extracts ([Figures 2](#fig2){ref-type="fig"}A and 2B), together with the other components of the active helicase. We then repeated the same experiment using the *ufd1-2 npl4-1* double mutant in parallel with a control strain but first grew cells at the permissive temperature of 24°C and synchronized them in G1 phase before raising the temperature to 37°C and allowing cells to enter S phase ([Figure 2](#fig2){ref-type="fig"}C). As described above, Cdc48-Ufd1-Npl4 co-purified with the helicase from S phase extracts of control cells, but all three proteins failed to associate with CMG in extracts of the *ufd1-2 npl4-1* mutant ([Figure 2](#fig2){ref-type="fig"}D; [Figures S2](#mmc1){ref-type="supplementary-material"}D and S2E show that the *ufd1-2* mutation makes the major contribution to this phenotype). These data indicate that the Ufd1-Npl4 heterodimer is required for recruitment of Cdc48 to the CMG helicase in budding yeast.

CMG Is Ubiquitylated on a Single Lysine in the Mcm7 Subunit {#sec2.3}
-----------------------------------------------------------

Ufd1 and Npl4 both contain ubiquitin-binding modules ([@bib28], [@bib38], [@bib47]), leading us to investigate the role of Mcm7 ubiquitylation in Ufd1-Npl4-dependent recruitment of Cdc48 to the CMG helicase. To try and map the sites of SCF^Dia2^-dependent ubiquitylation by mass spectrometry, we first developed a strategy for enrichment of ubiquitylated Mcm7 from the isolated CMG complex after in vitro ubiquitylation of the helicase in extracts of S phase cells (see [Experimental Procedures](#sec4){ref-type="sec"}). Initially, however, repeated attempts to map the ubiquitylation sites in trypsin-digested Mcm7 were unsuccessful, despite over 90% coverage of the peptide sequence. Therefore, we took an alternative approach by mutating clusters of surface lysine residues ([Figure 3](#fig3){ref-type="fig"}A), predicted by comparison with crystal structures of archaeal MCM proteins ([@bib5]). The mutated Mcm7 proteins (or wild-type Mcm7) were expressed in *mcm7-td* cells ([Figure 3](#fig3){ref-type="fig"}B), in which the endogenous *MCM7* gene was tagged with the heat-inducible degron ([@bib15]), to allow rapid degradation at 37°C in the presence of the E3 ubiquitin ligase Ubr1 ([@bib23]). Cells were arrested at 24°C in G2/M phase with nocodazole before induced expression of Ubr1 and mutated/wild-type Mcm7 from the *GAL1* promoter, followed by degradation of Mcm7-td at 37°C. The cells were subsequently allowed to divide, arrested transiently in the subsequent G1 phase, and then finally released into S phase ([Figure 3](#fig3){ref-type="fig"}C) before isolation of the GINS component of the CMG helicase from cell extracts.

Whereas degradation of Mcm7-td was sufficient to block CMG assembly in the subsequent S phase ([Figure 3](#fig3){ref-type="fig"}D, sample 1), this defect could be rescued by expression of wild-type Mcm7 ([Figure 3](#fig3){ref-type="fig"}D, sample 2). Moreover, CMG complexes containing wild-type Mcm7 were ubiquitylated efficiently in the yeast cell extracts ([Figure 3](#fig3){ref-type="fig"}D, sample 2). Ubiquitylation was not affected by mutating clusters of predicted surface lysines in the C-terminal half of Mcm7 (data summarized in [Figure 3](#fig3){ref-type="fig"}A). In contrast, mutation of the first seven lysines of Mcm7 blocked in vitro ubiquitylation, indicating that the modification was restricted to the amino terminus of the Mcm7 protein. Strikingly, subsequent deconvolution experiments (summarized in [Figure 3](#fig3){ref-type="fig"}A) showed that the first lysine of Mcm7 was essential for the observed in vitro ubiquitylation ([Figures 3](#fig3){ref-type="fig"}C and 3D, sample 3, *mcm7-K29A*).

Lysine 29 is located within the longest tryptic peptide of Mcm7, probably contributing to the initial difficulty in detecting the sites of Mcm7 ubiquitylation by mass spectrometry. Therefore, we combined trypsin with the endoproteinase GluC that cuts after glutamate residues to reduce the size of the cleaved peptide containing K29. After partial purification of Mcm7 from isolated CMG helicase that had been ubiquitylated in yeast cell extracts ([Figure S3](#mmc1){ref-type="supplementary-material"}A), subsequent analysis of peptides cleaved with trypsin and GluC revealed a single site of in vitro ubiquitylation of Mcm7, namely K29 ([Figure S3](#mmc1){ref-type="supplementary-material"}C; [Table S1](#mmc1){ref-type="supplementary-material"}). Moreover, K29 was also the only detectable site of in vivo ubiquitylation of Mcm7 when we purified the CMG helicase from high salt cell extracts after inactivation of Cdc48 to block the disassembly of ubiquitylated CMG at the end of S phase ([Figures S3](#mmc1){ref-type="supplementary-material"}B and S3D; [Table S1](#mmc1){ref-type="supplementary-material"}). These experiments indicate that SCF^Dia2^-dependent ubiquitylation of the 11-subunit CMG helicase is remarkably specific both in vivo and in yeast cell extracts.

CMG Ubiquitylation Promotes Recruitment of Ufd1-Npl4-Cdc48 {#sec2.4}
----------------------------------------------------------

Mapping and mutating the site of Mcm7 modification allowed us to explore in vitro the role of ubiquitylation in recruitment of Ufd1-Npl4-Cdc48 to the CMG helicase. We generated haploid yeast strains in which the endogenous *MCM7* locus was modified in order to introduce the *mcm7-K29A* or *mcm7-K29R* mutations (see [Experimental Procedures](#sec4){ref-type="sec"}). In extracts of synchronized S phase cell cultures, we found that either mutation abolished in vitro ubiquitylation of the CMG helicase, compared to control cell extracts ([Figures 4](#fig4){ref-type="fig"}A, 4B, [S4](#mmc1){ref-type="supplementary-material"}A, and S4B). Whereas Ufd1-Npl4-Cdc48 associated with the ubiquitylated CMG helicase in control cell extracts as described above ([Figure 4](#fig4){ref-type="fig"}B, *MCM7*), this association was greatly diminished when in vitro ubiquitylation of CMG was blocked by mutation of K29 of Mcm7 ([Figure 4](#fig4){ref-type="fig"}B, *mcm7-K29A*). These findings indicate that ubiquitylation of Mcm7 plays an important role in recruiting Ufd1-Npl4-Cdc48 to the CMG helicase.

In Vivo Ubiquitylation of Mcm7-K29A during Termination {#sec2.5}
------------------------------------------------------

Lysine 29 of Mcm7 is the only detectable site of CMG ubiquitylation in wild-type yeast cells both in vivo and in vitro ([Figure S3](#mmc1){ref-type="supplementary-material"}), and mutation of K29 abolishes in vitro CMG ubiquitylation in yeast cell extracts ([Figures 3](#fig3){ref-type="fig"}D and [4](#fig4){ref-type="fig"}B). Nevertheless, we found that another site (or other sites) on Mcm7 can be ubiquitylated in vivo when *mcm7-K29A* cells complete S phase ([Figures S4](#mmc1){ref-type="supplementary-material"}C--S4E, *mcm7-K29A*, sample 2). Moreover, in vivo ubiquitylation of Mcm7-K29A occurs with comparable efficiency to CMG ubiquitylation on lysine 29 of Mcm7 in wild-type cells ([Figure S4](#mmc1){ref-type="supplementary-material"}E, sample 2; compare *MCM7* with *mcm7-K29A*). Interestingly, therefore, the regulation of CMG ubiquitylation ensures that it is highly specific in wild-type yeast cells, being limited to a single lysine residue on Mcm7, and yet is still able to switch elsewhere on Mcm7 with high efficiency when K29 of Mcm7 is mutated (note that we cannot exclude the alternative possibility that Mcm7 in wild-type cells is ubiquitylated in vivo, but not in vitro, on another site that is not detected in our mass spectrometry assays, in addition to ubiquitylation of K29). Ubiquitylation of CMG in yeast cell extracts is more constrained, at least under our in vitro conditions, such that K29 of Mcm7 is the only possible acceptor site for ubiquitin.

In vivo ubiquitylation of Mcm7-K29A on the alternative site(s) appears to be functionally important during DNA replication termination, because CMG disassembly is highly efficient when *mcm7-K29A* cells complete S phase ([Figures S4](#mmc1){ref-type="supplementary-material"}F and S4G). As would be expected, therefore, *mcm7-K29A* cells grow like a wild-type strain and lack phenotypes of *dia2Δ* cells ([@bib32]), such as synthetic lethality upon deletion of the gene encoding the Rrm3 DNA helicase ([Figure S4](#mmc1){ref-type="supplementary-material"}H).

Discussion {#sec3}
==========

Our data lead to a revised model for CMG disassembly in budding yeast, beginning with the addition of a K48-linked ubiquitin chain ([@bib26]) to the Mcm7 subunit of the helicase at the end of chromosome replication, dependent upon SCF^Dia2^ ([Figure 4](#fig4){ref-type="fig"}C). Ubiquitylation of CMG then drives recruitment of Cdc48, via the Ufd1-Npl4 heterodimer. Finally, the Cdc48 segregase disassembles the CMG helicase and releases its component parts from chromatin. The role of the Ufd1-Npl4 heterodimer in CMG disassembly is likely to be conserved in all eukaryotes. Previous work showed that depletion of the orthologues of Ufd1 or Npl4 led to persistence of Cdc45 or GINS on mitotic chromatin in early embryos of the nematode *Caenorhabditis elegans* or in egg extracts of the frog *Xenopus laevis* ([@bib17]). Although these findings were thought to reflect a post-replicative role for UFD1-NPL4-CDC48 in extracting GINS and Cdc45 (but not Mcm2--7) from chromatin during mitosis, we found that depletion of UFD-1, NPL-4, or CDC-48 in *C. elegans* early embryos leads to persistence of ubiquitylated CMG helicase ([@bib43]). Moreover, UFD1-NPL4-p97 are recruited to chromatin during DNA replication termination in frog egg extracts ([@bib13]) and associate with ubiquitylated CMG helicase ([@bib43]). These data indicate a conserved mechanism for CMG disassembly from yeast to animals.

The triggers for CMG ubiquitylation during the termination of replication remain to be defined. It is possible that the helicases at converged forks slide onto double-stranded DNA (dsDNA) when they meet the 5′ end of the opposing fork's lagging strand, as CMG disassembly has been shown to occur after all DNA intermediates have been ligated and DNA synthesis is complete ([@bib12]). The change from encircling single-stranded DNA (ssDNA) to dsDNA might provide a signal for ubiquitylation ([@bib12]), as might the detachment of the helicase from DNA at telomeres, where termination only involves a single fork. We suggest that such changes in helicase action at the end of replication produce a structural change in CMG that favors ubiquitylation of the amino terminal site in Mcm7. In this context, it is interesting to note that lysine 29 of Mcm7 is located within "sub-domain A," which in archaeal MCM helicases undergoes a 150° rotation between different structural forms ([@bib6], [@bib30]). More recently, electron microscopy structures of yeast Mcm2--7 ([@bib24]) and *Drosophila* CMG ([@bib1]) indicate that sub-domain A of Mcm7 rotates significantly between the loaded inactive Mcm2--7 complex and the active CMG helicase. It thus seems plausible that structural changes in sub-domain A of Mcm7 might represent a conformational switch on the CMG helicase during termination, for example, revealing a docking site for the ubiquitin ligase or otherwise controlling the access of the ligase to K29. Ubiquitylation of Mcm7 then promotes recruitment of Ufd1-Npl4 and thus of Cdc48, leading locally to helicase disassembly after DNA synthesis has been completed in each particular replicon.

It remains to be determined how ubiquitylation of CMG is restricted to a specific lysine residue in wild-type cells, and yet is able to switch in vivo (but not in cell extracts) to other sites upon mutation of lysine 29 of Mcm7. It will be important in future studies to map and mutate the alternative sites of ubiquitylation of Mcm7-K29A. The ultimate goal would be to create a non-ubiquitylatable version of the CMG helicase, in order to test directly the significance of CMG ubiquitylation for helicase disassembly at the end of chromosome replication and explore the importance of CMG ubiquitylation for genome integrity in yeast cells that still contain active SCF^Dia2^.

Experimental Procedures {#sec4}
=======================

Yeast Strains {#sec4.1}
-------------

[Table S2](#mmc1){ref-type="supplementary-material"} lists the yeast strains used in this study. All genetic modifications were initially made in the diploid budding-yeast strain W303-1. Following confirmation of the genome modification by a series of PCR reactions, the haploid strains used for subsequent analyses were obtained by tetrad dissection.

The *TET-shp1-aid* allele was constructed using a modified version of the auxin-inducible degron system ([@bib36], [@bib44]). First, the tetracycline-repressible promotor was introduced at the 5′ end of the *SHP1* gene in diploid cells expressing the rice Tir1 E3 ubiquitin ligase. Subsequently, the "3× mini auxin-inducible degron" cassette was introduced at the 3′ end of the *SHP1* coding sequence.

A two-step strategy was used to introduce the *mcm7-K29A* or *mcm7-K29R* mutations into the endogenous *MCM7* locus in budding yeast cells. First, the region encoding amino acids 1--64 of Mcm7 was replaced with the URA3 marker, in one copy of *MCM7* in diploid cells, to produce *MCM7*/*mcm7Δ*::*URA3*. Second, the entire *MCM7* locus was PCR amplified with flanking sequences from *MCM7-5FLAG9His* cells, in which the *hphNT* hygromycin-resistance marker is located after the tag at the end of MCM7 coding sequence. The resulting fragment was cloned into pBluescript II KS+, and site-directed mutagenesis was used to introduce the K29A or K29R mutations. The resulting fragments were then excised and transformed into the heterozygous *MCM7*/*mcm7Δ*::*URA3* diploid cells. Selection for the *hphNT* marker and confirmation of loss of *URA3* led to the isolation of *MCM7*/*mcm7-K29A-5FLAG9His*::*hphNT* and *MCM7*/*mcm7-K29R-5FLAG9His*::*hphNT* diploid strains. The *mcm7-K29A-5FLAG9His*::*hphNT* and *mcm7-K29R-5FLAG9His*::*hphNT* haploid strains were then derived by sporulation and tetrad dissection of the corresponding diploids before final confirmation of the mutations by DNA sequencing.

The temperature-sensitive strains *ufd1-2* and *npl4-1* were a generous gift from Raymond Deshaies and, before use, were backcrossed eight times with our wild-type W303 strains.

Growing Yeast Liquid Cultures {#sec4.2}
-----------------------------

Unless otherwise stated, budding yeast cells were grown in standard YP medium (1% yeast extract; 2% peptone) containing 2% glucose (YPD). For the cultures involving *mcm7-td* strains ([Figure 3](#fig3){ref-type="fig"}), cells were inoculated at 24°C the previous day in YP supplemented with 2% raffinose (YPRaff) and 0.1 mM copper (II) sulfate and then diluted in the same medium the next morning before growth of a mid-log culture. Expression of the Ubr1 E3 ubiquitin ligase was then induced by switching the medium to YP supplemented with 2% galactose (YPGal), first at 24°C for 30 min and subsequently at 37°C for 60 min.

Other yeast cultures were grown at 24°C or 30°C. In order to arrest cells in the G1 phase of the cell cycle, the mating pheromone alpha factor (Pepceuticals) was initially added to cultures at 7.5 μg/mL and then supplemented by an additional 2.5 μg/mL every 20 min after 60 min from initial incubation (for cultures grown at 30°C or every 30 min after 90 min if the cultures were grown at 24°C) until 90% or more of cells formed "shmoos". For *dia2Δ* cells, as well as for *ufd1-2* and *npl4-1* cells, the additional supplements of alpha factor were increased to 5 μg/mL.

For the experiments shown in [Figure 3](#fig3){ref-type="fig"}, 5 μg/mL nocodazole was used to arrest cells in the G2/M phase of the cell cycle. After induction of *GAL-UBR1* in YPGal medium, cells were washed into YPGal medium containing 10 μg/mL alpha factor, and additional aliquots of 2.5 μg/mL alpha factor were then added after 30 min and then again every 15 min.

To arrest cells in early S phase, cells were grown in the presence of 0.2 M hydroxyurea (HU).

Degradation of the Shp1-aid protein (in the experiment shown in [Figure S1](#mmc1){ref-type="supplementary-material"}D) was induced by the addition for 3 hr of auxins (1 mM indole-3-acetic acid and 0.5 mM 1-napthaleneacetic acid) and 20 μg/mL doxycycline to an asynchronous mid-log culture at 30°C, which was grown overnight in the presence of 0.25 μg/mL doxycycline.

Tetrad Dissection {#sec4.3}
-----------------

For the experiments shown in [Figures 1](#fig1){ref-type="fig"}E and [S4](#mmc1){ref-type="supplementary-material"}H, *dia2Δ* cells were mated with cells with deletions of Cdc48 cofactors or to cells with the temperature-sensitive mutations *ufd1-2* and *npl4-1* at 30°C due to the cold sensitivity of *dia2Δ* cells. Sporulated diploids were then dissected and plates were incubated at 30°C for 2 days. The genotype of the haploid progeny was determined by replica plating to selective media.

Dilution Spotting {#sec4.4}
-----------------

For the experiment shown in [Figure S1](#mmc1){ref-type="supplementary-material"}C, cells were diluted to 3 × 10^6^, 3 × 10^5^, 3 × 10^4^, and 3 × 10^3^ cells/mL in PBS. Spots containing 50 × 10^4^, 50 × 10^3^, 50 × 10^2^, or 50 cells were then placed on the indicated media (YPD or YPD + 0.5 mM IAA + 0.5 mM NAA + 20 μg/mL doxycycline).

Flow Cytometry {#sec4.5}
--------------

The content of DNA in cells was monitored by flow cytometry of fixed cells stained with propidium iodide ([@bib23]). Flow cytometers used in this study were FACSCalibur and FACSCanto II (Becton Dickinson). The measurements were analyzed with FlowJo software (Tree Star).

Immunoprecipitation of Protein Complexes from Yeast Extracts {#sec4.6}
------------------------------------------------------------

The isolation of protein complexes from budding yeast cell extracts was performed as described previously ([@bib26]). In the experiments shown in [Figures 1](#fig1){ref-type="fig"}C, 1D, [2](#fig2){ref-type="fig"}, [S1](#mmc1){ref-type="supplementary-material"}, [S2](#mmc1){ref-type="supplementary-material"}B, [S3](#mmc1){ref-type="supplementary-material"}B, S3D, [S4](#mmc1){ref-type="supplementary-material"}A, and S4B, the deubiquitylase inhibitor propargylated ubiquitin (Ub-Prg, supplied by the Protein Production Team of the MRC PPU at the University of Dundee) was added to cell extracts to a final concentration of 5μM. For in vitro ubiquitylation experiments, Ub-Prg was added to low salt yeast cell extracts upon thawing, whereas, for in vivo ubiquitylation experiments, the Ubi-Prg was first added to the "high-salt lysis buffer," in which cells were frozen and then Ub-Prg was also added to the thawed cell extracts as above.

Isolation of Ubiquitylated Mcm7 for Mass Spectrometry Analysis {#sec4.7}
--------------------------------------------------------------

After in vitro ubiquitylation in low-salt extracts (100 mM potassium acetate) or in vivo ubiquitylation after inactivation of Cdc48-aid (using high salt extracts with 700 mM potassium acetate to block in vitro ubiquitylation plus 5 μM Ub-Prg to inhibit deubiquitylases), we isolated the Mcm7 subunit of the CMG helicase using the two-step purification procedure that we described previously ([@bib26]).

Mass Spectrometry and Data Analysis {#sec4.8}
-----------------------------------

Peptides were extracted using the in-gel tryptic digestion protocol described previously ([@bib42]). The extracted tryptic peptides were then resuspended in 26 μL 0.5% acetic acid, 0.1% trifluoroacetic acid (TFA) ready for mass spectrometry analysis or for further digestion with Glu-C. Peptides from approximately half of this volume were purified using "stop and go extraction tips" ([@bib40]) and then resuspended in 20 μL of 50 mM ammonium bicarbonate containing 0.2 μg endoproteinase Glu-C (sequencing grade; Roche) before incubation for 16 hr at room temperature. The Glu-C digestions were dried down using a vacuum centrifuge at 30°C, and the resultant doubly digested peptides were resuspended in 20 μL of 0.5% acetic acid and 0.1% TFA ready for mass spectrometry analysis. In this way, two peptide samples were generated for each slice of gel and digested either just with trypsin or else with trypsin + Glu-C.

Mass spectrometry analysis was performed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) (Q Exactive; Thermo Fisher Scientific) equipped with an integrated nano-electrospray (Easy-Spray; Thermo Fisher Scientific) coupled to a nano-uHPLC system (Easy N-LC-1000; Thermo Fisher Scientific). Peptides were fractionated on a 50 cm × 75 μm internal diameter, PepMap RSLC C18, 2 μm reverse-phase column heated to 45°C. For initial analysis, between 2 and 6 μL peptide samples were loaded and fractionated over a 60-min gradient. Data were acquired in the data-dependent mode. Full scan spectra (*m/z* 300--1,800) were acquired in the Orbitrap with resolution *R* = 70,000 at *m/z* 200 (after accumulation to a target value of 1,000,000 or 20 ms). The ten most intense ions were fragmented by "higher energy collisional dissociation" (resolution 17,500 at *m/z* 200 and target value of 500,000 or 60 ms). Precursor ions of unassigned charge, +1, or \>+8 charge were excluded from the MS/MS analysis. The intensity threshold was set to 2 × 10^4^. To obtain higher quality spectra of GlyGly-K-containing peptides, further MS runs were performed on the doubly digested peptides (trypsin + GluC) using the same parameters as described above, with the exception of selecting only the top seven peptides for MS/MS analysis at a resolution of 35,000, with a target value of 1,000,000 ions or a fill time of 150 ms.

All the raw MS data files were analyzed together using the quantitative MS software MaxQuant ([@bib8]) incorporating the Andromeda search engine (version 1.5.2.8; [@bib9]). An *S*. *cerevisiae* protein database was searched along with the exact sequence of the Mcm7-5FLAG-9His construct. Enzyme specificity was set to trypsin-P or trypsin-P + Glu-C as required. Cysteine carbamidomethylation was selected as a fixed modification and GlyGly-lysine, methionine oxidation, and protein N-acetylation were searched as variable modifications. The initial maximum allowed mass deviation was set to 20 parts per million (ppm) for peptide masses and 0.5 Da for MS/MS peaks. The minimum peptide length was set to seven amino acids and a maximum of two missed cleavages (Trypsin-P) or three missed cleavages (Trypsin-P + Glu-C). A 1% false discovery rate (FDR) was required at both the protein and peptide level. In addition to the FDR threshold, proteins were considered as "identified," if they had at least one unique peptide. Protein identifications and intensity values based on extracted ion chromatograms were reported for each slice from each gel lane. Spectral annotations were performed automatically in MaxQuant.

Immunoblotting {#sec4.9}
--------------

Polyclonal antibodies for the detection of replisome components and Cdc48 by immunoblotting were described previously ([@bib16], [@bib19], [@bib20], [@bib26]). Polyclonal antibodies against full-length Ufd1 and Npl4 1-222 were produced by MRC PPU reagents (<https://mrcppureagents.dundee.ac.uk>) at the University of Dundee.
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![Ufd1-Npl4 Are Required for Disassembly of the CMG Helicase at the End of Chromosome Replication in Budding Yeast\
(A) Asynchronous cultures of control cells (YASD375) and *npl4-1* (YMM308) were grown at 24°C and then shifted to 37°C for 1 hr before making cell extracts in the presence of 700 mM potassium acetate, in order to block in vitro ubiquitylation of CMG. The Sld5 subunit of GINS was then isolated by immunoprecipitation and the association of other CMG components monitored by immunoblotting. In vivo ubiquitylation of the Mcm7 subunit of CMG was observed in the *npl4-1* strain.\
(B) A similar experiment to that above was performed with control cells (YASD375) and *ufd1-2* (YMM306).\
(C) Control cells (YSS47) and *ufd1-2 npl4-1* cells (YMM574) were synchronized in G1 phase at 24°C and then released into S phase in the presence of 0.2 M hydroxyurea for 70 min to allow for CMG assembly at forks from early origins of replication. The cells were then shifted to 37°C for 60 min to inactivate Ufd1-Npl4, before washing into fresh medium lacking hydroxyurea, to allow cells to complete chromosome replication. Mating pheromone was added 45 min after release to prevent dividing cells from entering another round of S phase. DNA content was monitored by flow cytometry throughout the experiment, as shown in the panels.\
(D) CMG was monitored as above by immunoprecipitation of the Sld5 subunit of GINS from high-salt extracts. Inactivation of Ufd1-Npl4 blocked CMG disassembly at the end of replication, leading to accumulation of CMG with in vivo ubiquitylated Mcm7.\
(E) The indicated diploid strains (YMM562 and YMM563) were sporulated and the meiotic progeny dissected before growth for 2 days at 30°C. The genotype of each colony was then determined by replica plating to selective medium or to rich medium at 37°C.\
See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![Ufd1-Npl4 Are Required to Recruit Cdc48 to the CMG Helicase\
(A) *TAP-SLD5* cells (YSS47) were synchronized in G1 phase at 24°C and then released into S phase for the indicated times. DNA content was measured by flow cytometry.\
(B) The association of Ufd1, Npl4, and Cdc48 with CMG was monitored by immunoprecipitation of GINS from G1 phase or S phase cells (30 min time point) under conditions that favor SCF^Dia2^-dependent in vitro ubiquitylation of the helicase.\
(C) Control (YSS47) and *ufd1-2 npl4-1* cells (YMM574) were synchronized in G1 phase at 24°C and then shifted to 37°C for 60 min before release into S phase for 15 min.\
(D) The association of Ufd1, Npl4, and Cdc48 with CMG was monitored as above.](gr2){#fig2}

![In Vitro Ubiquitylation of CMG in Yeast Cell Extracts Is Dependent upon Lysine 29 of Mcm7\
(A) Summary of screen for alleles of Mcm7 that cannot be ubiquitylated in vitro.\
(B) Experimental scheme.\
(C) DNA content was monitored by flow cytometry at the indicated time points.\
(D) CMG was monitored as above.\
See also [Figure S3](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![Ubiquitylation of the Mcm7 Subunit of CMG Drives Recruitment of Ufd1-Npl4-Cdc48\
(A) Control (YGDP483) and *mcm7-K29A* (YMM493) yeast cells were synchronized in G1 phase at 30°C and then released into S phase for 20 min.\
(B) The association of Ufd1, Npl4, and Cdc48 with CMG was monitored as above.\
(C) Model for CMG disassembly at the end of chromosome replication in budding yeast. Note that the fate of ubiquitylated Mcm7 after CMG disassembly is unknown.\
See also [Figure S4](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}
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